Understanding clinical trial terminology helps you navigate the research process with confidence. ← Back to Blog
Clinical Trial: A research study that tests whether a new medical treatment, drug, device, or procedure works in human subjects and is safe.
Protocol: The detailed plan for the trial. It specifies what the study will do, how participants will be selected, what happens during the trial, and how safety and results will be monitored. When researchers talk about ‘following protocol,’ they mean sticking to this plan.
Hypothesis: The prediction that researchers want to test. Example: ‘We believe this medication will reduce symptoms by at least 30 percent.’
Primary Outcome: The main thing the trial is measuring. This is the question that matters most—Does the treatment work? Secondary outcomes are additional things being tracked but aren’t the trial’s central focus.
Phase: Trials move through phases. Phase 1 tests safety in a small group. Phase 2 tests effectiveness in a larger group. Phase 3 compares the new treatment to current standard treatment in a large group. Phase 4 continues testing after approval. Higher phases mean more evidence exists.
Control Group: Participants who receive either a placebo (an inactive substance) or the current standard treatment, not the experimental treatment. This allows researchers to compare whether the new treatment actually works better.
Randomization: The process of randomly assigning participants to receive either the experimental treatment or the control treatment. This reduces bias and ensures groups are comparable.
Principal Investigator (PI): The senior researcher leading the trial. This is the person ultimately responsible for how the study is conducted.
Study Coordinator: Your main point of contact. They schedule your visits, answer questions, explain procedures, and ensure you understand what’s happening. Good coordinators make trials feel less confusing.
Research Assistant: Supports the coordinator by taking measurements, drawing blood, administering questionnaires, and helping with day-to-day trial tasks.
Institutional Review Board (IRB): A committee that reviews the trial before it starts to ensure it’s ethical and that participant safety is protected. The IRB continues monitoring throughout the trial.
Data Safety Monitoring Board (DSMB): An independent group that watches trial data as it comes in. If results show the experimental treatment is clearly working, they can recommend early approval. If safety problems emerge, they can stop the trial.
Placebo: An inactive substance designed to look like the real treatment but contains no active ingredient. Placebos help researchers understand whether improvement comes from the treatment itself or from other factors like expectations or natural recovery.
Double-Blind: Neither you nor the researchers know who is receiving the experimental treatment and who is receiving the placebo or control treatment. This prevents bias from influencing results.
Blinded: You don’t know which treatment you’re receiving. In single-blind trials, only participants are blinded. In open-label trials, everyone knows what treatment is being given.
Dosage: The amount of medication or treatment you receive. Dose escalation means gradually increasing the amount to find the best effective dose with acceptable side effects.
Adverse Event: Any unwanted medical occurrence during a trial, whether or not it seems related to the treatment. This includes side effects, hospitalizations, or any health change that researchers need to know about.
Serious Adverse Event (SAE): An adverse event severe enough to warrant stopping the trial for that participant, may result in hospitalization, permanent disability, or life threat.
Informed Consent: The document explaining the trial in detail—what you’ll do, what risks exist, what benefits might occur, your rights, and how your data will be used. You must read and sign this before joining. Informed consent is a process, not just a form. You can ask questions anytime.
Confidentiality: Your medical information is protected. Researchers can’t share your personal data without permission. Your trial information may be coded with a number instead of your name to maintain privacy.
Right to Withdraw: You can leave a trial anytime, for any reason, without penalty. You don’t owe researchers an explanation.
Data Integrity: The accuracy and trustworthiness of trial information. Researchers follow strict procedures to ensure data is recorded correctly and not falsified.
IRB Approval: Official permission from the Institutional Review Board that a trial can proceed. This means the study design is ethical and participant protections are adequate.
Understanding these terms helps you evaluate whether a trial makes sense for you and gives you a framework for asking better questions. Don’t hesitate to ask a study coordinator to explain anything that isn’t clear. They’re there to help you make an informed decision. When you’re ready to explore specific trials, trialport can connect you with opportunities that match your condition and your preferences.
For more information about clinical trials in your area, visit TrialPort, a platform connecting patients with clinical trial opportunities.
